- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
InfiMed upgrades digital products
Advanced image processing features, an expanded DICOM interface, and a newly designed CCD camera system are among the enhancements now available on InfiMed's PlatinumOne Cardiac package. The company has also upgraded its PlatinumOne Combo system with
Advanced image processing features, an expanded DICOM interface, and a newly designed CCD camera system are among the enhancements now available on InfiMed's PlatinumOne Cardiac package. The company has also upgraded its PlatinumOne Combo system with real-time digital subtraction for interventional vascular as well as cardiac procedures.
Philips launches radiotherapy software Three new radiation oncology products from Philips Medical Systems were showcased at the meeting of the American Association of Physics in Medicine July 25 to 29 in Pittsburgh. The software products, which earlier cleared the FDA, run on Philips' Pinnacle3 radiation therapy planning system. Conformal Arc radiation planning software helps target hundreds of radiation beams. Modeling tools enhance accuracy and save time by providing a more exact representation of the linear accelerator's parameters. In addition, a sliding-window intensity-modulated radiation therapy planning tool creates a highly conformal dose distribution.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
